N'-[1-Cyclopenylamino-2-phenylidene]hydrazinecarboxylic acid tert-butyl ester, 95.0%, 1g

Tris(4-(dimethylamino)phenyl)methanol, 98%, 5g

3-Amino-N-(2-methoxyphenyl)-4-(morpholin-4-yl)benzene-1-sulfonamide, 98%, 250mg

(3R,5R)-tert-Butyl 7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate, 98%, 5g

8-benzyl-4-heptanoyl-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

Fmoc-L-phenylglycinol, 98.0%, 5g

(S)-Methyl 2-hydroxy-3-methylbutanoate, 95.0%, 5g

Methyl carbamimidate hydrochloride, 95.0%, 5g

5-BROMO-2-CYCLOBUTYLPYRIDINE, 95.0%, 1g

Morpholine>99.0%(GC)(T)500mL

(R)-4-(6,7-DIHYDRO-5H-PYRROLO[1,2-C]IMIDAZOL-5-YL)-3-FLUOROBENZONITRILE, 95.0%, 25mg

3-methoxy-3-methylbut-1-yne, 95.0%, 1g

4-(5-Methyl-3-phenylisoxazol-4-yl)benzenesulfonamide, 95.0%, 5g